Bradley Yuen

Sengkang General Hospital, Senior Podiatrist, Podiatry Association (Singapore).

Mr. Yuen is an Australian-trained Senior Podiatrist with extensive experience in high-risk and sports podiatry, with a particular interest in limb salvage and preservation. With a background in health management and clinical leadership, he has experience in healthcare service development, multidisciplinary collaboration, mentorship, and the delivery of patient-centred care.

He has a strong interest in healthcare innovation and the application of emerging technologies to clinical practice. His work includes the development and implementation of an in-house 3D-printed custom insole service, integrating digital foot scanning, 3D modelling, and additive manufacturing to improve access to patient-specific foot orthoses, reduce production turnaround times, and support evidence-based clinical practice.

Mr. Yuen is passionate about education and professional development, providing clinical mentorship to podiatric medicine students and healthcare professionals across multidisciplinary settings. His professional interests encompass clinical innovation, research, service development, technology-enabled healthcare, and advancing the role of podiatry in improving patient outcomes.

He maintains professional affiliations with the Australian Podiatry Association, Podiatry Association Singapore, and the American Limb Preservation Society (ALPS), and is registered with the Australian Health Practitioner Regulation Agency (AHPRA).

Transforming Diabetic Foot Care Through Digitally Enabled 3D-Printed Insoles: From Innovation to Clinical Implementation

Custom foot insoles play a vital role in reducing plantar pressure and preventing diabetic foot ulceration, yet conventional manufacturing is often labour-intensive, costly and time-consuming.

This presentation describes the implementation of a hospital-based digital workflow integrating 3D foot scanning, computer-aided design and in-house additive manufacturing to deliver personalised insoles for patients with diabetes.

We will share our implementation journey and present clinical and service outcomes, including comparable peak plantar pressure reduction, reduced turnaround time and production costs, and increased service capacity.